PaxMedica, Inc. Common Stock
PXMD
PXMD was delisted on the 1st of May, 2024.
1 hedge funds and large institutions have $12 invested in PaxMedica, Inc. Common Stock in 2024 Q2 according to their latest regulatory filings, with 0 funds opening new positions, 0 increasing their positions, 1 reducing their positions, and 7 closing their positions.
88% less funds holding
Funds holding: 8 → 1 (-7)
100% less capital invested
Capital invested by funds: $64.7K → $12 (-$64.7K)
100% less first-time investments, than exits
New positions opened: 0 | Existing positions closed: 7
100% less repeat investments, than reductions
Existing positions increased: 0 | Existing positions reduced: 1
Top Buyers
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
SFA
Souders Financial Advisors
Cincinnati,
Ohio
|
-$20.4K |
| 2 |
VF
Virtu Financial
New York
|
-$19K |
| 3 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
-$13.3K |
| 4 |
TSS
Two Sigma Securities
New York
|
-$8.41K |
| 5 |
TRCT
Tower Research Capital (TRC)
New York
|
-$3.58K |
PXMD Hedge Fund Activity: Q2 2024 in Review
1 of the 6,935 institutional investors tracked by Wall St. Rank reported a position in PaxMedica, Inc. Common Stock (PXMD) for Q2 2024, worth a combined $12 — down 100% from $64.7K a quarter earlier.
Sellers outnumbered buyers: 7 funds closed out of PXMD and 0 opened new positions — a net loss of 7 holders — while 1 trimmed existing stakes and 0 added.
The largest seller was Souders Financial Advisors, exiting entirely with an estimated $20.4K sold.
- 1 institutional investor held PaxMedica, Inc. Common Stock (PXMD) as of Q2 2024, down from 8 in Q1 2024.
- Funds reported $12 of PaxMedica, Inc. Common Stock stock for Q2 2024, down 100% quarter-over-quarter.
- 0 funds opened new PaxMedica, Inc. Common Stock positions in Q2 2024 and 7 closed out, a net change of -7 holders.
- The largest PaxMedica, Inc. Common Stock seller in Q2 2024 was Souders Financial Advisors, an estimated $20.4K sold.
Based on aggregated 13F filings for Q2 2024.